Antimonopoly Groups Push for Corporate Probes, Antitrust Bills if Jamie Raskin Takes House Judiciary Committee Gavel Next Year

Health Care Weekly: Liquidia Drug Marketing for Lung Condition Found to Violate Rival’s Patent After ‘At-Risk’ Launch; CMS Slashes Scope of GLOBE Pricing Model; FDA Seeks Input on Psychedelic Made From Tree Bark; Medline Hospital Bed Recall Tops 1 Million; GAO Report Says Vertical Integration in Pharmacy Saves Patients Money; FTC Presses Hospitals to Post Prices; HHS Seeks to Speed Drug Trials

The Health Care Weekly is a timely analysis of competition developments, policy changes and other updates that may affect medical and pharmaceutical markets. Key stories we’re following this week...

Life & Annuity Industry: Regulators Seek Visibility into Potential Solvency Risks Posed by Funding Agreement-Backed Notes

The rapid emergence of funding agreement-backed notes (FABNs), which have helped to fuel life insurers’ investments in private credit, is drawing scrutiny from the National Association of Insurance...

Raising Red Flags: A Closer Look at RH’s Pattern of Overly Optimistic Guidance

Raising Red Flags is a new accounting-focused newsletter from The Capitol Forum’s Corporate Investigations team. If you would like to receive future editions and do not currently subscribe to...